Markus J. Cappel
2021
In 2021, Markus J. Cappel earned a total compensation of $2.6M as Chief Business Officer at ChemoCentryx, a 15% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $175,443 |
|---|---|
| Option Awards | $635,149 |
| Salary | $464,135 |
| Stock Awards | $1,284,465 |
| Other | $4,004 |
| Total | $2,563,196 |
Cappel received $1.3M in stock awards, accounting for 50% of the total pay in 2021.
Cappel also received $175.4K in non-equity incentive plan, $635.1K in option awards, $464.1K in salary and $4K in other compensation.
Rankings
In 2021, Markus J. Cappel's compensation ranked 5,058th out of 12,415 executives tracked by ExecPay. In other words, Cappel earned more than 59.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,058 out of 12,415 | 59th |
Division Manufacturing | 2,129 out of 5,505 | 61st |
Major group Chemicals And Allied Products | 912 out of 2,375 | 62nd |
Industry group Drugs | 816 out of 2,096 | 61st |
Industry Pharmaceutical Preparations | 584 out of 1,546 | 62nd |
Source: SEC filing on April 5, 2022.
Cappel's colleagues
We found four more compensation records of executives who worked with Markus J. Cappel at ChemoCentryx in 2021.